Readers should review current FDA guidance, verify pharmacy licensing, read all safety information carefully, and consult a licensed clinician before making treatment decisions
The non-selectivity is both MT-2's strength (diverse pharmacology) and its weakness (unpredictable multi-system effects and increased side effect burden)
Compliance was tracked via weekly check-ins, and IIEF-5 was measured at baseline, week 6, and week 12
This helps your body adjust and can make side effects easier to manage but it also means results often build gradually instead of showing up right away
The study highlighted an important finding: At high per-cycle SPPS yields, linear synthesis can outperform fragment-based approaches, delivering higher overall yields, and simpler, more cost efficient manufacturing processes
Food and Drug Administration (FDA) has approved it to treat